SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA)
CUSIP: P8696W104
Q3 2021 13F Holders as of 30 Sep 2021
- Type / Class
- Equity / Common Shares, par value US$0.001 per share
- Shares outstanding
- 71,872,133
- Total 13F shares
- 6,692,031
- Share change
- -352
- Total reported value
- $43,303,000
- Price per share
- $6.47
- Number of holders
- 14
- Value change
- -$2,609
- Number of buys
- 1
- Number of sells
- 2
Quarterly Holders Quick Answers
What is CUSIP P8696W104?
CUSIP P8696W104 identifies SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP P8696W104:
Top shareholders of SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| SAIF Advisors Ltd |
13F
|
Company |
15%
|
10,780,820
|
$405,359,000 | — | 30 Jun 2021 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
4%
|
2,839,500
|
$76,800,000 | — | 30 Jun 2021 | |
| Vivo Capital, LLC |
13F
|
Company |
8.2%
|
5,900,000
|
$38,173,000 | — | 30 Jun 2021 | |
| Neumann Advisory Hong Kong Ltd |
13F
|
Company |
0.44%
|
315,586
|
$2,042,000 | — | 30 Jun 2021 | |
| STATE STREET CORP |
13F
|
Company |
0.39%
|
281,640
|
$1,822,000 | — | 30 Jun 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
3.3%
|
2,375,841
|
$1,537,000 | — | 30 Jun 2021 | |
| Yorktown Management & Research Co Inc |
13F
|
Company |
0.1%
|
74,893
|
$485,000 | — | 30 Jun 2021 | |
| Skandinaviska Enskilda Banken AB (publ) |
13F
|
Company |
0.06%
|
40,000
|
$259,000 | — | 30 Jun 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
27,717
|
$179,000 | — | 30 Jun 2021 | |
| Freedom Investment Management, Inc. |
13F
|
Company |
0.02%
|
17,879
|
$116,000 | — | 30 Jun 2021 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.02%
|
16,430
|
$106,000 | — | 30 Jun 2021 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
9,095
|
$59,000 | — | 30 Jun 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.02%
|
13,787
|
$55,000 | — | 30 Jun 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
3,841
|
$25,000 | — | 30 Jun 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
3,000
|
$19,000 | — | 30 Jun 2021 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
412
|
$3,000 | — | 30 Jun 2021 | |
| HARBOUR INVESTMENTS, INC. |
13F
|
Company |
0%
|
180
|
$1,000 | — | 30 Jun 2021 | |
| Financial Gravity Asset Management, Inc. |
13F
|
Company |
0%
|
123
|
$6 | — | 30 Jun 2021 |
Institutional Holders of SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA) as of Q3 2021
As of 30 Sep 2021,
SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,692,031 shares.
The largest 10 holders included
Vivo Capital, LLC, Neumann Advisory Hong Kong Ltd, STATE STREET CORP, Yorktown Management & Research Co Inc, Skandinaviska Enskilda Banken AB (publ), GEODE CAPITAL MANAGEMENT, LLC, Eqis Capital Management, Inc., SUSQUEHANNA INTERNATIONAL GROUP, LLP, UBS Group AG, and MORGAN STANLEY.
This page lists
14
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
15
Q3 2021 holders
14
Holder diff
-1
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 Value $ | Q3 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.